127 related articles for article (PubMed ID: 12399188)
1. Preadolescent non- and hyporesponders following three doses of hepatitis B vaccine need only one more dose.
Duval B; Boulianne N; De Serres G; De Wals P; Massé R; Trudeau G
Vaccine; 2002 Nov; 20(31-32):3632-4. PubMed ID: 12399188
[TBL] [Abstract][Full Text] [Related]
2. The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population.
Jacques P; Moens G; Desombere I; Dewijngaert J; Leroux-Roels G; Wettendorff M; Thoelen S
Vaccine; 2002 Nov; 20(31-32):3644-9. PubMed ID: 12399191
[TBL] [Abstract][Full Text] [Related]
3. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
[TBL] [Abstract][Full Text] [Related]
4. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
[TBL] [Abstract][Full Text] [Related]
5. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure.
Watkins SL; Alexander SR; Brewer ED; Hesley TM; West DJ; Chan IS; Mendelman P; Bailey SM; Burns JL; Hogg RJ;
Am J Kidney Dis; 2002 Aug; 40(2):365-72. PubMed ID: 12148110
[TBL] [Abstract][Full Text] [Related]
6. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.
Elisbão Mdo C; Baldy JL; Bonametti AM; Reiche EM; Morimoto HK; Pontello R; Matsuo T; Ferelle A; Neves J
Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1109-13. PubMed ID: 15049099
[TBL] [Abstract][Full Text] [Related]
7. The effects of booster vaccination of hepatitis B vaccine on children 5-15 years after primary immunization: A 5-year follow-up study.
Wu Z; Yao J; Bao H; Chen Y; Lu S; Li J; Yang L; Jiang Z; Ren J; Xu KJ; Ruan B; Yang SG; Xie TS; Li Q
Hum Vaccin Immunother; 2018 May; 14(5):1251-1256. PubMed ID: 29337651
[TBL] [Abstract][Full Text] [Related]
8. Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillance.
Clemens R; Sänger R; Kruppenbacher J; Höbel W; Stanbury W; Bock HL; Jilg W
Vaccine; 1997 Mar; 15(4):349-52. PubMed ID: 9141203
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients.
Gilbert CL; Stek JE; Villa G; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
Vaccine; 2014 Nov; 32(48):6521-6. PubMed ID: 25252192
[TBL] [Abstract][Full Text] [Related]
10. Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine.
Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Deceuninck G; Massé R; Duval B
Hum Vaccin; 2010 Feb; 6(2):212-8. PubMed ID: 19946212
[TBL] [Abstract][Full Text] [Related]
11. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
[TBL] [Abstract][Full Text] [Related]
12. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
Chow KM; Law MC; Leung CB; Szeto CC; Li PK
Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
[TBL] [Abstract][Full Text] [Related]
14. The persistence of anti-hepatitis B surface antibodies to three years of age: is a hepatitis B vaccine booster required?
Gunn TR; Woodfield DG
N Z Med J; 1993 Nov; 106(968):499-501. PubMed ID: 8247433
[TBL] [Abstract][Full Text] [Related]
15. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
Jafarzadeh A; Zarei S; Shokri F
Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
[TBL] [Abstract][Full Text] [Related]
16. Antibody response to hepatitis B vaccine in infants of HIV-positive mothers.
Watanaveeradej V; Samakoses R; Kerdpanich A; Aree C; Nitayabhan S; Viputtikul K; Sukwit S
Int J Infect Dis; 2002 Sep; 6(3):240-1. PubMed ID: 12718844
[No Abstract] [Full Text] [Related]
17. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
Zanetti AR; Romanò L; Giambi C; Pavan A; Carnelli V; Baitelli G; Malchiodi G; Valerio E; Barale A; Marchisio MA; Montù D; Tozzi AE; D'Ancona F;
Lancet Infect Dis; 2010 Nov; 10(11):755-61. PubMed ID: 20884297
[TBL] [Abstract][Full Text] [Related]
18. The implication of a reduced-dose hepatitis B vaccination schedule in low risk newborns.
Lee SS; Young BW; Wong KH; Lim WL
Vaccine; 2002 Nov; 20(31-32):3752-4. PubMed ID: 12399205
[TBL] [Abstract][Full Text] [Related]
19. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.
Velu V; Nandakumar S; Shanmugam S; Shankar EM; Thangavel S; Kulkarni PS; Thyagarajan SP
Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
